Loading...
Wayland Group Corp.
MRRCF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$0.00(0.00%)

Wayland Group Corp. (MRRCF) Cash Flow Analysis
The cash flow statement reveals the Wayland Group Corp. (MRRCF) liquidity trends, with operating cash flow per share at $-0.24, reflecting core business performance. Investing activity changes were N/A, indicating capital expenditures or asset sales, while financing activity shifted by N/A, showing debt or equity movements. Free cash flow per share was $-0.46, highlighting funds available for growth or shareholder returns. Year-over-year change in operating cash flow is N/A, demonstrating financial health shifts. For deeper insights, compare these figures with income statements and balance sheets to assess sustainability and strategic priorities.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan